[1]郭献飞,王广新,苏国海.心脏负荷试验在冠状动脉粥样硬化性心脏病
预后评估中的应用[J].国际心血管病杂志,2022,04:219-222.
点击复制
心脏负荷试验在冠状动脉粥样硬化性心脏病
预后评估中的应用(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2022年04期
- 页码:
- 219-222
- 栏目:
- 综述
- 出版日期:
- 2022-08-30
文章信息/Info
- Title:
- -
- Author(s):
- -
- 关键词:
- 冠状动脉粥样硬化性心脏病; 心脏负荷试验; 预后评估
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2022.04.008
- 文献标识码:
- -
- 摘要:
- 动脉造影术是评估冠状动脉粥样硬化性心脏病（冠心病）的重要方法，但其高 成本、并发症多、无法评估微循环等，而心脏负荷试验是评估确诊或疑似缺血性心脏病患者 的重要方式，不仅能对冠心病进行诊断，而且可以评估预后。该文介绍心脏负荷试验在冠心 病预后评估中的应用。
- Abstract:
- -
参考文献/References
[1] Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and
stroke statistics-2017 update: a report from the American Heart
Association[J]. Circulation, 2017, 135:e146.
[2] Bargiel W, Cierpiszewska K, Maruszczak K, et al. Recognized
and potentially new biomarkers-their role in diagnosis and
prognosis of cardiovascular disease[J]. Medicine (Kaunas),
2021, 57(7):701.
[3] Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/
ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013
multimodality appropriate use criteria for the detection and
risk assessment of stable ischemic heart disease: a report of
the American College of Cardiology Foundation Appropriate
Use Criteria Task Force, American Heart Association,
American Society of Echocardiography, American Society of
Nuclear Cardiology, Heart Failure Society of America, Heart
Rhythm Society, Society for Cardiovascular Angiography
and Interventions, Society of Cardiovascular Computed
Tomography, Society for Cardiovascular Magnetic Resonance,
and Society of Thoracic Surgeons[J]. J Am Coll Cardiol, 2014,
63(4):380-406.
[4] Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA
guideline focused update on duration of dual antiplatelet
therapy in patients with coronary artery disease[J]. Circulation,
2016, 134(10):e123-e155.
[5] Wolk MJ, Bailey SR, Doherty JU, et al. ACCF 2013
multimodality appropriate use criteria for the detection and
risk assessment of stable ischemic heart disease: a report of
the American College of Cardiology Foundation Appropriate
Use Criteria Task Force, American Heart Association,
American Society of Echocardiography, American Society of
Nuclear Cardiology, Heart Failure Society of America, Heart
Rhythm Society, Society for Cardiovascular Angiography
and Interventions, Society of Cardiovascular Computed
Tomography, Society for Cardiovascular Magnetic Resonance,
and Society of Thoracic Surgeons[J]. J Am Coll Cardiol, 2014,
63(4):380-406.
[6] Pellikka PA, Nagueh SF, Elhendy AA, et al, American Society
of Echocardiography. American Society of Echocardiography
recommendations for performance, interpretation, and
application of stress echocardiography[J]. Am Soc
Echocardiogr, 2007, 20(9):1021-1041.
[7] 唐耀. 心电图运动负荷试验在冠心病治疗中的应用[J].中国
药物与临床, 2021, 21(13):2303-2304.
[8] Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for
testing and training: a scientific statement from the American
Heart Association[J]. Circulation, 2013, 128:873
[9] 陈琛, 潘道林, 丁良, 等. 动态心电图结合平板运动试验诊
断隐匿型冠心病的临床价值[J]. 实用心电学杂志, 2019,
28(3):192-195.
[10] Smith L, Myc L, Watson D, et al. A high exercise workload
of ≥ 10 METS predicts a low risk of significant ischemia
and cardiac events in older adults[J]. Nucl Cardiol, 2020,
27(5):1486-1496.
[11] Thomas GS, Cullom SJ, Kitt TM, et al. The EXERRT trial:"exercise to regadenoson in recovery trial": a phase 3b, openlabel,
parallel group, randomized, multicenter study to assess
regadenoson administration following an inadequate exercise
stress test as compared to regadenoson without exercise for
myocardial perfusion imaging using a SPECT protocol[J].
Nucl Cardiol, 2017, 24:788.
[12] Iskandar A, Limone B, Parker MW, et al. Gender differences
in the diagnostic accuracy of SPECT myocardial perfusion
imaging: a bivariate meta-analysis[J]. Nucl Cardiol, 2013,
20(1):53-63.
[13] Humbert O, Noirot E, Leclerc T, et al. Comparison of the
prognostic value of different clinical, angiographic and
scintigraphic scores in stable coronary patients after acute
coronary syndrome[J]. Ann Cardiol Angeiol (Paris), 2020,
69(1):12-23.
[14] Navare SM, Mather JF, Shaw LJ, et al. Comparison of
risk stratification with pharmacologic and exercise stress
myocardial perfusion imaging: a meta-analysis[J]. Nucl
Cardiol, 2004, 11:551.
[15] Henzlova MJ, Duvall WL, Einstein AJ, et al. ASNC imaging
guidelines for SPECT nuclear cardiology procedures: stress,
protocols, and tracers[J]. Nucl Cardiol, 2016, 23:606.
[16] Kattoor AJ, Kolkailah AA, Iskander F, et al. The prognostic
value of regadenoson SPECT myocardial perfusion imaging:
the largest cohort to date[J]. J Nucl Cardiol, 2021, 28(6):2799-
2807.
[17] Sidhu GS, Hendel RC. The evolution of the prognostic value
of regadenoson SPECT myocardial perfusion imaging[J]. J
Nucl Cardiol, 2021, 28(6):2808-2811.
[18] Takeuchi M, Wu VC. Application of left ventricular strain to
patients with coronary artery disease[J]. Curr Opin Cardiol.
2018, 33(5):464-469.
[19] 张运, 尹立雪, 邓又斌, 等. 负荷超声心动图规范化操作指南[J].
中国医学影像技术, 2017, (4):632-638.
[20] Johnson NP, Goldberger JJ. Prognostic value of late heart
rate recovery after treadmill exercise[J]. Am J Cardiol, 2012,
110(5):763.
[21] 宋雨微, 井玲. 负荷超声心动图在缺血性心脏病中的临床应
用进展[J]. 心血管病学进展, 2021, 42(1):47-51.
[22] Marwick TH, Case C, Sawada S, et al. Prediction of mortality
using dobutamine echocardiography[J]. Coll Cardiol, 2001,
37:754.
[23] Uusitalo V, Luotolahti M, Pietil? M, et al. Two-dimensional
speckle-tracking during dobutamine stress echocardiography
in the detection of myocardial ischemia in patients with
suspected coronary artery disease[J]. J Am Soc Echocardiogr,
2016, 29(5):470-479.
[24] Ilardi F, Santoro C, Cirillo P, et al. Quantitative detection
of inducible ischemia during dobutamine stress by speckle
tracking echocardiography: a dream comes true[J]. Cardiol,
2016, 220:357-359.
[25] 王家鑫, 杨凯, 赵世华. 2020 SCMR心血管磁共振临床指征
专家共识解读[J]. 磁共振成像, 2021, 12(5):85-89.
[26] Nagel E, Greenwood JP. McCann GP, et al. Magnetic
resonance perfusion or fractional flow reserve in coronary
disease[J]. N Engl J Med, 2019, 381(23):2276-2277.
[27] Marcos-Garces V, Gavara J, Monmeneu JV, et al. A novel
clinical and stress cardiac magnetic resonance (C-CMR-10)
score to predict long-term all-cause mortality in patients with
known or suspected chronic coronary syndrome[J]. Clin Med,
2020, 9(6):1957.
[28] Catalano O, Moro G, Mori A, et al. Cardiac magnetic
resonance in stable coronary artery disease: added prognostic
value to conventional risk profiling[J]. Biomed Res Int, 2018,
2018:2806148.
备注/Memo
- 备注/Memo:
-
基金项目：国家科技重大专项课题（2020ZX09201025）
通信作者：苏国海， E-mail: suguohai65@163.com
常用功能
统计/Statistics
- 摘要浏览/Viewed69
- 全文下载/Downloads513
- 评论/Comments
